Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium
Yakeel T. Quiroz, Michele M. Solis, María Aranda, Alicia I. Arbaje, Mirna L Arroyo‐Miranda, Laura Y. Cabrera, Minerva M. Carrasquillo, María M. Corrada, Lucía Crivelli, Erica D. Diminich, Karen A. Dorsman, Mitzi M. Gonzales, Héctor M. González, Ana L. Gonzalez‐Seda, Lea T. Grinberg, Lourdes R. Guerrero, Carl V. Hill, Ivonne Z. Jiménez‐Velázquez, Jorge J. Llibre Guerra, Francisco Lopera, Gladys E. Maestre, Luis D. Medina, Sid E. O’Bryant, Claudia Peñaloza, Maria Mora Pinzón, Rosa V. Pirela Mavarez, Celina F. Pluim, Rema Raman, Katya Rascovsky, Dorene M. Rentz, Yarissa Reyes, Mónica Rosselli, Malú G. Tansey, Clara Vila‐Castelar, Megan Zuelsdorff, María C. Carrillo, Claire E. Sexton
Abstract
The Alzheimer's Association hosted the second Latinos & Alzheimer's Symposium in May 2021. Due to the COVID-19 pandemic, the meeting was held online over 2 days, with virtual presentations, discussions, mentoring sessions, and posters. The Latino population in the United States is projected to have the steepest increase in Alzheimer's disease (AD) in the next 40 years, compared to other ethnic groups. Latinos have increased risk for AD and other dementias, limited access to quality care, and are severely underrepresented in AD and dementia research and clinical trials. The symposium highlighted developments in AD research with Latino populations, including advances in AD biomarkers, and novel cognitive assessments for Spanish-speaking populations, as well as the need to effectively recruit and retain Latinos in clinical research, and how best to deliver health-care services and to aid caregivers of Latinos living with AD.